Effective reduction of biofilm through photothermal therapy by gold core@shell based mesoporous silica nanoparticles

TL;DR

This study develops gold core@shell mesoporous silica nanoparticles that combine photothermal therapy, nitric oxide release, and antibiotic delivery to effectively disrupt and inhibit bacterial biofilms, offering a promising new antimicrobial strategy.

Contribution

The paper introduces a novel nanoparticle system integrating photothermal, nitric oxide, and antibiotic functionalities for enhanced biofilm eradication.

Findings

NIR irradiation causes ca. 90% reduction in biofilm mass.

Nitrosothiol groups enable nitric oxide release upon photothermal stimulation.

Combined therapy significantly outperforms individual treatments.

Abstract

Bacterial biofilms can initiate chronic infections that become difficult to eradicate. There is an unmet need for effective therapeutic strategies that control and inhibit the growth of these biofilms. Herein, light sensitive mesoporous silica nanoparticles (MSNs) with photothermal (PTT) and antimicrobial combined capabilities have been developed. These nanosystems have high therapeutic potential to affect the bacterial biofilm architecture and subsequently inhibit its growth. Nucleation of gold nanorods followed by the growth of a silica shell leads to a core@shell design (AuNR@MSN) with PTT properties. Incorporation of nitrosothiol groups (-SNO) with a heat liable linker, enables an enhanced nitric oxide release upon photothermal stimulation with near infrared radiation. Further loading of an antimicrobial molecule such as the levofloxacin (LEVO) antibiotic creates a unique nanoassembly with potential therapeutic efficacy against Staphylococcus aureus bacterial biofilms. A dispersion rate of the bacterial biofilm was evident when light stimuli is applied because impregnation of the nitrosothiol functionalized nanosystem with the antibiotic LEVO led to ca. 30% reduction but its illumination with near infrared (NIR) irradiation showed a biofilm reduction of ca. 90%, indicating that localized antimicrobial exposure and PTT improves the therapeutic efficacy. These findings envision the conception of near-infraredactivated nanoparticle carriers capable of combined therapy upon NIR irradiation, which enables photothermal therapy, together with the release of levofloxacin and nitric oxide to disrupt the integrity of bacterial biofilms and achieve a potent antimicrobial therapy.